Mersana Therapeutics, Inc. Total Assets
Mersana Therapeutics, Inc. had Total Assets of $62.69 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2025-11-14
- 2025-09-30: Assets $62.69M.
- 2025-06-30: Assets $84.57M.
- 2025-03-31: Assets $112.47M.
- 2024-12-31: Assets $144.66M.
| Period end | Assets |
|---|---|
| 2025-09-30 | $62.69M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $84.57M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $112.47M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $144.66M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $169.53M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $179.13M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $198.37M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $226.06M 10-K · filed 2025-03-03 |
| 2023-09-30 | $262.90M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $311.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $296.19M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $334.34M 10-K · filed 2024-02-28 |
| 2022-09-30 | $314.85M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $252.35M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $258.27M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $206.11M 10-K · filed 2023-02-28 |
| 2021-09-30 | $217.59M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $253.69M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $247.91M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $273.40M 10-K · filed 2022-02-28 |
| 2020-09-30 | $290.13M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $310.52M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $95.86M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $107.54M 10-K · filed 2021-02-26 |
| 2019-09-30 | $121.66M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $139.38M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $149.39M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $78.50M 10-K · filed 2020-02-28 |
| 2018-09-30 | $94.38M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $106.91M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $115.75M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $130.72M 10-K · filed 2019-03-08 |
| 2017-09-30 | $142.92M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $85.22M 10-Q · filed 2017-08-11 |
| 2016-12-31 | $105.09M 10-K · filed 2018-03-28 |